ATE203161T1 - Polymer umhüllte tablette enthaltend amoxicillin und clavulanat - Google Patents

Polymer umhüllte tablette enthaltend amoxicillin und clavulanat

Info

Publication number
ATE203161T1
ATE203161T1 AT95917937T AT95917937T ATE203161T1 AT E203161 T1 ATE203161 T1 AT E203161T1 AT 95917937 T AT95917937 T AT 95917937T AT 95917937 T AT95917937 T AT 95917937T AT E203161 T1 ATE203161 T1 AT E203161T1
Authority
AT
Austria
Prior art keywords
clavulanate
coated tablet
tablet containing
polymer coated
containing amoxicillin
Prior art date
Application number
AT95917937T
Other languages
English (en)
Inventor
C P Conley
N P Davidson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE203161(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE203161T1 publication Critical patent/ATE203161T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT95917937T 1994-04-23 1995-04-19 Polymer umhüllte tablette enthaltend amoxicillin und clavulanat ATE203161T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9408117A GB9408117D0 (en) 1994-04-23 1994-04-23 Pharmaceutical formulations
PCT/EP1995/001463 WO1995028927A1 (en) 1994-04-23 1995-04-19 Polymer coated tablet comprising amoxycillin and clavulanate

Publications (1)

Publication Number Publication Date
ATE203161T1 true ATE203161T1 (de) 2001-08-15

Family

ID=10754044

Family Applications (6)

Application Number Title Priority Date Filing Date
AT99200891T ATE223706T1 (de) 1994-04-23 1995-04-19 Tabletten enthaltend amoxicillin und clavulanate, die mit einem polymerüberzug versehen sind
AT95917937T ATE203161T1 (de) 1994-04-23 1995-04-19 Polymer umhüllte tablette enthaltend amoxicillin und clavulanat
AT00204182T ATE226074T1 (de) 1994-04-23 1995-04-19 Verfahren zur herstellung von tabletten enthaltend amoxicillin und clavulanate, die mit einem polymerfilm auf wasserbasis versehen sind
AT96202848T ATE196845T1 (de) 1994-04-23 1995-04-19 Verfahren zur herstellung von tabletten enthaltend amoxicillin und clavulanate, die mit einem polymerfilm auf wasserbasis versehen sind
AT0052400U AT5349U1 (de) 1994-04-23 2000-07-18 Polymerbeschichtete tablette umfassend amoxycillin und clavulanat
AT0028501U AT5350U1 (de) 1994-04-23 2001-04-11 Medikament zur oralen verabreichung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99200891T ATE223706T1 (de) 1994-04-23 1995-04-19 Tabletten enthaltend amoxicillin und clavulanate, die mit einem polymerüberzug versehen sind

Family Applications After (4)

Application Number Title Priority Date Filing Date
AT00204182T ATE226074T1 (de) 1994-04-23 1995-04-19 Verfahren zur herstellung von tabletten enthaltend amoxicillin und clavulanate, die mit einem polymerfilm auf wasserbasis versehen sind
AT96202848T ATE196845T1 (de) 1994-04-23 1995-04-19 Verfahren zur herstellung von tabletten enthaltend amoxicillin und clavulanate, die mit einem polymerfilm auf wasserbasis versehen sind
AT0052400U AT5349U1 (de) 1994-04-23 2000-07-18 Polymerbeschichtete tablette umfassend amoxycillin und clavulanat
AT0028501U AT5350U1 (de) 1994-04-23 2001-04-11 Medikament zur oralen verabreichung

Country Status (35)

Country Link
US (1) US6051255A (de)
EP (5) EP1243267A3 (de)
JP (1) JP3622975B2 (de)
CN (1) CN1134258C (de)
AP (2) AP564A (de)
AT (6) ATE223706T1 (de)
AU (1) AU684949B2 (de)
BG (1) BG62842B1 (de)
BR (1) BR9507502A (de)
CA (1) CA2188496A1 (de)
CZ (2) CZ11376U1 (de)
DE (5) DE69528608T2 (de)
DK (4) DK0761218T3 (de)
DZ (1) DZ1876A1 (de)
ES (4) ES2180251T3 (de)
FI (1) FI964249A (de)
GB (1) GB9408117D0 (de)
GR (2) GR3035031T3 (de)
HK (5) HK1036404A1 (de)
HU (1) HU228399B1 (de)
IL (1) IL113433A (de)
MA (1) MA23528A1 (de)
MY (1) MY115351A (de)
NO (1) NO310703B1 (de)
NZ (1) NZ285080A (de)
OA (1) OA10377A (de)
PL (1) PL316966A1 (de)
PT (4) PT761218E (de)
RO (1) RO116997B1 (de)
RU (1) RU2152213C1 (de)
SA (1) SA95160343B1 (de)
SI (1) SI0758235T1 (de)
SK (1) SK282594B6 (de)
WO (1) WO1995028927A1 (de)
ZA (1) ZA953236B (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
CN1289084C (zh) 1995-09-07 2006-12-13 史密丝克莱恩比彻姆有限公司 药物制剂
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
WO1998034598A2 (en) * 1997-02-07 1998-08-13 Gist-Brocades B.V. Homogeneous granulated formulations for dose sipping technology
DE69815833T2 (de) * 1997-02-14 2004-05-19 Laboratoire Glaxosmithkline S.A.S. Amoxicillin und clavulanat enthaltende arzneizubereitungen
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
CN1268888A (zh) * 1997-08-29 2000-10-04 Dsm公司 不含赋形剂的颗粒
EP1032425A1 (de) 1997-10-31 2000-09-06 Monsanto Company Gellangummi-tablettenbeschichtungen
US6979735B1 (en) 1999-04-01 2005-12-27 Dsm N.V. Agglomerates by crystallization
SK285140B6 (sk) * 1999-04-13 2006-07-07 Beecham Pharmaceuticals (Pte) Limited Použitie amoxycilínu a klavulanátu draselného a farmaceutický prípravok s ich obsahom
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6756057B2 (en) * 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) * 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
AU2003210925A1 (en) * 2002-02-07 2003-09-02 Rutgers, The State University Antibiotic polymers
US20050075335A1 (en) * 2002-02-14 2005-04-07 Buxton Philip Christopher Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation
GB0203528D0 (en) * 2002-02-14 2002-04-03 Glaxo Group Ltd Process and composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528189A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
CA2533358C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653925A1 (de) * 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robustes pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8246996B2 (en) * 2003-08-29 2012-08-21 Shionogi Inc. Antibiotic product, use and formulation thereof
DE10341264A1 (de) 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
CA2538064C (en) * 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
US7884112B2 (en) 2004-03-08 2011-02-08 Stuart Edward Bradley Pyrrolopyridine-2-carboxylic acid hydrazides
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
KR101318032B1 (ko) 2005-05-20 2013-10-14 다이이찌 산쿄 가부시키가이샤 필름 코팅 제제
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
CN104739821B (zh) * 2009-09-18 2018-04-06 赛诺菲 稳定性提高的(z)‑2‑氰基‑3‑羟基‑丁‑2‑烯酸‑(4’‑三氟甲基苯基)‑酰胺片剂制剂
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) * 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (de) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmazeutische Zubereitung die Beta-Lactam Antibiotika enthält
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
SK285140B6 (sk) * 1999-04-13 2006-07-07 Beecham Pharmaceuticals (Pte) Limited Použitie amoxycilínu a klavulanátu draselného a farmaceutický prípravok s ich obsahom
WO2002030392A2 (en) * 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin

Also Published As

Publication number Publication date
HK1027024A1 (en) 2001-01-05
AP9500733A0 (en) 1995-04-30
DE69519093D1 (de) 2000-11-16
DE69521799T2 (de) 2002-06-13
NO964488D0 (no) 1996-10-22
SK282594B6 (sk) 2002-10-08
AP9600868A0 (en) 1996-10-31
HU228399B1 (en) 2013-03-28
RO116997B1 (ro) 2001-09-28
ZA953236B (en) 1995-12-27
MY115351A (en) 2003-05-31
EP0978276B1 (de) 2002-09-11
DK0758235T3 (da) 2001-10-29
DK1093813T3 (da) 2003-02-17
EP1093813A2 (de) 2001-04-25
DE69528204D1 (de) 2002-10-17
ES2152485T3 (es) 2001-02-01
ES2180251T3 (es) 2003-02-01
AU2406895A (en) 1995-11-16
BG62842B1 (bg) 2000-09-29
CA2188496A1 (en) 1995-11-02
EP0978276A2 (de) 2000-02-09
EP0758235A1 (de) 1997-02-19
PT761218E (pt) 2001-03-30
DE29522153U1 (de) 2000-04-06
DK0761218T3 (da) 2000-12-18
EP0761218A1 (de) 1997-03-12
ES2161288T3 (es) 2001-12-01
HK1050992A1 (zh) 2003-07-18
WO1995028927A1 (en) 1995-11-02
ES2182754T3 (es) 2003-03-16
CZ294168B6 (cs) 2004-10-13
HK1021860A1 (en) 2000-07-07
OA10377A (en) 2001-11-21
GR3035031T3 (en) 2001-03-30
DK0978276T3 (da) 2003-01-20
EP1243267A3 (de) 2002-10-30
DZ1876A1 (fr) 2002-02-17
DE69521799D1 (de) 2001-08-23
CZ309096A3 (en) 1997-04-16
HUT76335A (en) 1997-08-28
EP0758235B1 (de) 2001-07-18
SK135496A3 (en) 1997-05-07
CN1149829A (zh) 1997-05-14
EP1093813A3 (de) 2001-05-30
SA95160343B1 (ar) 2005-05-04
SI0758235T1 (en) 2001-10-31
HK1009936A1 (en) 1999-06-11
DE69528204T2 (de) 2003-08-07
NO964488L (no) 1996-12-17
HK1036404A1 (en) 2002-01-04
NO310703B1 (no) 2001-08-20
BR9507502A (pt) 1997-09-02
AU684949B2 (en) 1998-01-08
AP564A (en) 1996-11-21
JPH09512027A (ja) 1997-12-02
PL316966A1 (en) 1997-03-03
AT5349U1 (de) 2002-06-25
MA23528A1 (fr) 1995-12-31
IL113433A0 (en) 1995-07-31
EP1093813B1 (de) 2002-10-16
EP0761218B1 (de) 2000-10-11
AT5350U1 (de) 2002-06-25
PT978276E (pt) 2003-01-31
DE69528608T2 (de) 2003-06-26
GB9408117D0 (en) 1994-06-15
CN1134258C (zh) 2004-01-14
DE69528608D1 (de) 2002-11-21
CZ11376U1 (cs) 2001-07-12
ATE196845T1 (de) 2000-10-15
FI964249A0 (fi) 1996-10-22
PT1093813E (pt) 2003-02-28
EP0978276A3 (de) 2000-04-12
BG100933A (en) 1997-07-31
PT758235E (pt) 2001-10-31
RU2152213C1 (ru) 2000-07-10
NZ285080A (en) 1998-05-27
FI964249A (fi) 1996-10-22
GR3036844T3 (en) 2002-01-31
DE69519093T2 (de) 2001-07-19
IL113433A (en) 2003-06-24
ATE223706T1 (de) 2002-09-15
EP1243267A2 (de) 2002-09-25
HU9602922D0 (en) 1996-12-30
US6051255A (en) 2000-04-18
ATE226074T1 (de) 2002-11-15
JP3622975B2 (ja) 2005-02-23

Similar Documents

Publication Publication Date Title
ATE203161T1 (de) Polymer umhüllte tablette enthaltend amoxicillin und clavulanat
ATE243516T1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
HUP9901092A3 (en) Benzimidazole compounds and their pharmaceutical use
NO304488B1 (no) 5-leddede heteroaryloksazolidinoner, anvendelse av disse for fremstilling av legemidler samt legemiddel inneholdende forbindelsen
HK1043042A1 (zh) 含有阿莫西林和棒酸鹽的藥用加工製劑
ZA966494B (en) New drugs and their use
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
DE69513671T2 (de) Arzneimittel
AU3460297A (en) Taxane derivatives and drugs containing the same
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
DE4494713T1 (de) Arylsulfonamidderivate und diese Derivate enthaltende Arzneimittel
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
HUP9602977A2 (en) Arylpiperidine and arylpiperazine derivatives and drugs containing the same
AU1081897A (en) Heterocyclic compounds and their use
ATE246499T1 (de) Trimebutinhaltiges arzneimittel und verfahren
BR9606066A (pt) Composto e formulação farmacêutica
DE69509621D1 (de) Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
AU6470996A (en) 4a-aryldecahydroisoquinoline compounds and medicinal uses thereof
AU8561998A (en) Cyclic compounds and medicinal use thereof
AU708571C (en) Novel heterocyclic derivatives and pharmaceutical use thereof
GB9520714D0 (en) Cephem compounds and pharmaceutical use thereoof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification